Titre : ARN des algues

ARN des algues : Questions médicales fréquentes

Termes MeSH sélectionnés :

Ventricular Function, Left
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "ARN des algues : Questions médicales les plus fréquentes", "headline": "ARN des algues : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les ARN des algues : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-23", "dateModified": "2025-03-20", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "ARN des algues" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "ARN", "url": "https://questionsmedicales.fr/mesh/D012313", "about": { "@type": "MedicalCondition", "name": "ARN", "code": { "@type": "MedicalCode", "code": "D012313", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D13.444.735" } } }, "about": { "@type": "MedicalCondition", "name": "ARN des algues", "alternateName": "RNA, Algal", "code": { "@type": "MedicalCode", "code": "D048030", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "James Umen", "url": "https://questionsmedicales.fr/author/James%20Umen", "affiliation": { "@type": "Organization", "name": "Donald Danforth Plant Science Center, St. Louis, Missouri 63132, USA; email: jumen@danforthcenter.org." } }, { "@type": "Person", "name": "Susana M Coelho", "url": "https://questionsmedicales.fr/author/Susana%20M%20Coelho", "affiliation": { "@type": "Organization", "name": "Laboratory of Integrative Biology of Marine Models (LBI2M), Station Biologique de Roscoff (SBR), CNRS, Sorbonne Université, 29680 Roscoff, France; email: cock@sb-roscoff.fr." } }, { "@type": "Person", "name": "R K Henderson", "url": "https://questionsmedicales.fr/author/R%20K%20Henderson", "affiliation": { "@type": "Organization", "name": "School of Chemical Engineering, The University of New South Wales, Sydney, 2052, Australia. Electronic address: r.henderson@unsw.edu.au." } }, { "@type": "Person", "name": "Deying Huang", "url": "https://questionsmedicales.fr/author/Deying%20Huang", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Fudan University, Shanghai, 200433, People's Republic of China." } }, { "@type": "Person", "name": "Jibiao Zhang", "url": "https://questionsmedicales.fr/author/Jibiao%20Zhang", "affiliation": { "@type": "Organization", "name": "Department of Environmental Science and Engineering, Fudan University, Shanghai, 200433, People's Republic of China. jbzhang@fudan.edu.cn." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Non-invasive myocardial work index contributes to early identification of impaired left ventricular myocardial function in uremic patients with preserved left ventricular ejection fraction.", "datePublished": "2022-08-13", "url": "https://questionsmedicales.fr/article/35964127", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12938-022-01023-5" } }, { "@type": "ScholarlyArticle", "name": "Ventricular Functional Analysis in Congenital Complete Heart Block Using Speckle Tracking: Left Ventricular Epicardial Compared to Right Ventricular Septal Pacing.", "datePublished": "2023-01-10", "url": "https://questionsmedicales.fr/article/36625944", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00246-022-03093-7" } }, { "@type": "ScholarlyArticle", "name": "Dapagliflozin, inflammation and left ventricular remodelling in patients with type 2 diabetes and left ventricular hypertrophy.", "datePublished": "2024-07-12", "url": "https://questionsmedicales.fr/article/38997620", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12872-024-04022-7" } }, { "@type": "ScholarlyArticle", "name": "Impact of right ventricular lead position on left ventricular functions and early remodeling in permanent single- and dual-chamber pacemakers.", "datePublished": "2022-09-21", "url": "https://questionsmedicales.fr/article/36129537", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00399-022-00896-2" } }, { "@type": "ScholarlyArticle", "name": "Impact of Impella protected-percutaneous coronary intervention on left ventricle function recovery of patients with extensive coronary disease and poor left ventricular function.", "datePublished": "2023-06-07", "url": "https://questionsmedicales.fr/article/37290663", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ijcard.2023.05.048" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides nucléiques, nucléotides et nucléosides", "item": "https://questionsmedicales.fr/mesh/D009706" }, { "@type": "ListItem", "position": 3, "name": "Acides nucléiques", "item": "https://questionsmedicales.fr/mesh/D009696" }, { "@type": "ListItem", "position": 4, "name": "ARN", "item": "https://questionsmedicales.fr/mesh/D012313" }, { "@type": "ListItem", "position": 5, "name": "ARN des algues", "item": "https://questionsmedicales.fr/mesh/D048030" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : ARN des algues - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur ARN des algues", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur ARN des algues", "description": "Comment détecte-t-on l'ARN des algues ?\nQuels tests sont utilisés pour l'ARN algal ?\nPeut-on identifier des algues par leur ARN ?\nL'ARN des algues est-il quantifiable ?\nQuels marqueurs sont utilisés pour l'ARN algal ?", "url": "https://questionsmedicales.fr/mesh/D048030?mesh_terms=Ventricular+Function,+Left&page=5#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur ARN des algues", "description": "Quels symptômes sont liés à l'ARN des algues ?\nL'ARN des algues cause-t-il des maladies ?\nY a-t-il des effets sur la santé liés à l'ARN algal ?\nComment l'ARN des algues affecte-t-il l'environnement ?\nDes symptômes neurologiques sont-ils possibles ?", "url": "https://questionsmedicales.fr/mesh/D048030?mesh_terms=Ventricular+Function,+Left&page=5#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur ARN des algues", "description": "Comment éviter l'exposition aux algues toxiques ?\nQuelles mesures de sécurité pour la consommation d'algues ?\nY a-t-il des recommandations pour les pêcheurs ?\nComment sensibiliser le public aux algues ?\nQuelles sont les bonnes pratiques pour la récolte d'algues ?", "url": "https://questionsmedicales.fr/mesh/D048030?mesh_terms=Ventricular+Function,+Left&page=5#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur ARN des algues", "description": "Comment traiter une intoxication par algues ?\nY a-t-il des antidotes pour les toxines algales ?\nPeut-on utiliser des algues en médecine ?\nQuels médicaments sont efficaces contre les effets des algues ?\nComment prévenir les effets néfastes des algues ?", "url": "https://questionsmedicales.fr/mesh/D048030?mesh_terms=Ventricular+Function,+Left&page=5#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur ARN des algues", "description": "Quelles complications peuvent survenir avec l'ARN algal ?\nL'ARN des algues peut-il causer des infections ?\nY a-t-il des risques à long terme liés aux algues ?\nComment les algues affectent-elles la chaîne alimentaire ?\nDes allergies aux algues sont-elles possibles ?", "url": "https://questionsmedicales.fr/mesh/D048030?mesh_terms=Ventricular+Function,+Left&page=5#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur ARN des algues", "description": "Quels sont les facteurs de risque d'intoxication par algues ?\nLes personnes âgées sont-elles plus à risque ?\nLes enfants sont-ils à risque avec les algues ?\nQuels environnements augmentent le risque d'algues ?\nLes personnes avec des allergies sont-elles plus à risque ?", "url": "https://questionsmedicales.fr/mesh/D048030?mesh_terms=Ventricular+Function,+Left&page=5#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment détecte-t-on l'ARN des algues ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'ARN des algues est détecté par des techniques comme la PCR et le séquençage." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour l'ARN algal ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent l'électrophorèse et l'hybridation de l'ARN." } }, { "@type": "Question", "name": "Peut-on identifier des algues par leur ARN ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'ARN permet d'identifier des espèces d'algues spécifiques." } }, { "@type": "Question", "name": "L'ARN des algues est-il quantifiable ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut être quantifié par des méthodes comme la RT-qPCR." } }, { "@type": "Question", "name": "Quels marqueurs sont utilisés pour l'ARN algal ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des marqueurs spécifiques comme les gènes ribosomaux sont souvent utilisés." } }, { "@type": "Question", "name": "Quels symptômes sont liés à l'ARN des algues ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes dépendent des algues, mais peuvent inclure des réactions allergiques." } }, { "@type": "Question", "name": "L'ARN des algues cause-t-il des maladies ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Certaines algues peuvent produire des toxines, entraînant des maladies." } }, { "@type": "Question", "name": "Y a-t-il des effets sur la santé liés à l'ARN algal ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à certaines algues peut provoquer des troubles gastro-intestinaux." } }, { "@type": "Question", "name": "Comment l'ARN des algues affecte-t-il l'environnement ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "L'ARN des algues peut influencer les écosystèmes aquatiques et la biodiversité." } }, { "@type": "Question", "name": "Des symptômes neurologiques sont-ils possibles ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Certaines algues toxiques peuvent provoquer des symptômes neurologiques." } }, { "@type": "Question", "name": "Comment éviter l'exposition aux algues toxiques ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez de nager ou de pêcher dans des zones avec des algues visibles." } }, { "@type": "Question", "name": "Quelles mesures de sécurité pour la consommation d'algues ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Consommez uniquement des algues provenant de sources fiables et testées." } }, { "@type": "Question", "name": "Y a-t-il des recommandations pour les pêcheurs ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Les pêcheurs doivent se renseigner sur les blooms algaux avant de pêcher." } }, { "@type": "Question", "name": "Comment sensibiliser le public aux algues ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des campagnes d'information peuvent aider à sensibiliser aux risques des algues." } }, { "@type": "Question", "name": "Quelles sont les bonnes pratiques pour la récolte d'algues ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Récoltez uniquement des algues identifiées et respectez les réglementations locales." } }, { "@type": "Question", "name": "Comment traiter une intoxication par algues ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement inclut l'hydratation et, dans certains cas, des médicaments spécifiques." } }, { "@type": "Question", "name": "Y a-t-il des antidotes pour les toxines algales ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas d'antidote universel, le traitement est symptomatique." } }, { "@type": "Question", "name": "Peut-on utiliser des algues en médecine ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines algues sont utilisées pour leurs propriétés médicinales." } }, { "@type": "Question", "name": "Quels médicaments sont efficaces contre les effets des algues ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments anti-inflammatoires et des antihistaminiques peuvent être utilisés." } }, { "@type": "Question", "name": "Comment prévenir les effets néfastes des algues ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Éviter la consommation d'algues non identifiées et se renseigner sur leur toxicité." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec l'ARN algal ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des troubles respiratoires et des réactions cutanées." } }, { "@type": "Question", "name": "L'ARN des algues peut-il causer des infections ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines algues peuvent être associées à des infections opportunistes." } }, { "@type": "Question", "name": "Y a-t-il des risques à long terme liés aux algues ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Une exposition prolongée peut entraîner des problèmes de santé chroniques." } }, { "@type": "Question", "name": "Comment les algues affectent-elles la chaîne alimentaire ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les algues peuvent perturber la chaîne alimentaire en affectant les espèces marines." } }, { "@type": "Question", "name": "Des allergies aux algues sont-elles possibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines personnes peuvent développer des allergies aux algues." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque d'intoxication par algues ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent la consommation d'algues non identifiées et la baignade en zones contaminées." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées peuvent être plus vulnérables aux effets des algues." } }, { "@type": "Question", "name": "Les enfants sont-ils à risque avec les algues ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants sont plus sensibles aux toxines algales en raison de leur taille." } }, { "@type": "Question", "name": "Quels environnements augmentent le risque d'algues ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Les environnements pollués et les eaux stagnantes favorisent la prolifération des algues." } }, { "@type": "Question", "name": "Les personnes avec des allergies sont-elles plus à risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes allergiques peuvent réagir plus fortement aux algues." } } ] } ] }

Sources (10000 au total)

Non-invasive myocardial work index contributes to early identification of impaired left ventricular myocardial function in uremic patients with preserved left ventricular ejection fraction.

Cardiac damage is the leading cause of death in uremic patients. This study aimed to evaluate the application of non-invasive myocardial work index (NIMWI) by echocardiography in assessing the left ve... Twenty-six uremic patients and 27 age- and sex-matched healthy volunteers were enrolled in the study. Except for the conventional echocardiographic parameters, the LV myocardial work (MW) parameters i... Compared with the normal group, GWW was significantly increased and GWE decreased in the uremic group (P < 0.05). Area under the curve (AUC) for GWE by the ROC analysis was 0.966. The best threshold, ... NIMWI may be applied to assess the global MW of uremic patients. The presence of reduced GWE can help identify impaired left ventricular myocardial function in uremic patients with preserved LV ejecti...

Ventricular Functional Analysis in Congenital Complete Heart Block Using Speckle Tracking: Left Ventricular Epicardial Compared to Right Ventricular Septal Pacing.

Chronic right ventricular (RV) apical pacing in patients with congenital complete atrioventricular block (CCAVB) is associated with left ventricle (LV) dyssynchrony and dysfunction. Hence, alternative... This was a single-center, retrospective study in patients with CCAVB who underwent permanent pacemaker implant at age ≤ 18 years. Age- and gender-matched patients with a normal heart anatomy and funct... We included 24 patients in the pacemaker group [27.6% male, mean age of 17.1 at last follow-up, follow-up duration of 8.7 years, RVSp (n = 9; 62.5%)] compared to 48 matched healthy controls. Shortenin... STE was more sensitive in detecting subtle differences in LV function relative to standard conventional 2D echocardiography (SF and EF) in selected patients with CCAVB and a permanent pacemaker. Furth...

Dapagliflozin, inflammation and left ventricular remodelling in patients with type 2 diabetes and left ventricular hypertrophy.

Sodium-glucose co-transporter 2 (SGLT2) inhibitors have beneficial effects in heart failure (HF), including reverse remodelling, but the mechanisms by which these benefits are conferred are unclear. I... We measured C-reactive protein (CRP), tumor necrosis factor alpha (TNF-α), interleukin-1β (IL-1β), interleukin 6 (IL-6), and interleukin 10 (IL-10) and neutrophil-to-lymphocyte ratio (NLR) in plasma s... Following 12 months of treatment dapagliflozin significantly reduced CRP compared to placebo (mean difference of -1.96; 95% CI -3.68 to -0.24, p = 0.026). There were no significant statistical changes... Dapagliflozin caused a significant reduction in CRP compared to placebo. There were correlations between reductions in inflammatory markers including IL-1β and improvements in global longitudinal stra... Clinicaltrials.gov NCT02956811 (06/11/2016)....

Impact of right ventricular lead position on left ventricular functions and early remodeling in permanent single- and dual-chamber pacemakers.

Right ventricular (RV) apical pacing can induce both interventricular dyssynchrony and intraventricular dyssynchrony. Mechanical dyssynchrony after long-term RV apical pacing is associated with reduce... We aimed to identify the short-term effects of the pacemaker RV lead position on remodeling of LV systolic functions.... The study included 30 patients who presented with an indication of permanent pacing and who underwent permanent single- or dual-chamber pacemaker insertion: 15 patients with RV apical pacing (RV apex)... At the 3‑month follow-up, post-pacing 2D speckle tracking echocardiography revealed impairment of global longitudinal strain in all patients and intraventricular dyssynchrony was significantly increas... In the short-term follow-up, 2D speckle tracking echocardiography showed more radial dyssynchrony in the apical location than in the non-apical location of RV lead. The RV septal pacing is a better al...

Impact of Impella protected-percutaneous coronary intervention on left ventricle function recovery of patients with extensive coronary disease and poor left ventricular function.

The use of Impella support is increasingly adopted to "protect" patients with severe coronary artery disease (CAD) and left ventricle (LV) dysfunction undergoing percutaneous coronary intervention (PC... To evaluate the impact of Impella-protected (Abiomed, Danvers, Massachusetts, USA) PCIs on myocardial function recovery.... Patients with significant LV dysfunction undergoing multi-vessel PCIs with pre-intervention Impella implantation were evaluated by echocardiography before PCI and at median follow up of 6 months: glob... A total of 48 high surgical risk (mean EuroSCORE II 8) patients with median LVEF value of 30%, extensive wall motion abnormalities (median WMSI 2.16), and severe multi-vessel CAD (mean SYNTAX score 35... In patients with extensive CAD and severe LV dysfunction, multi-vessel Impella-protected PCI was associated to an appreciable contractile recovery, mainly determined by regional wall motion improvemen...

Relationship between arterial stiffness, left ventricular diastolic function, and renal function in chronic kidney disease.

In chronic kidney disease, IgA nephropathy, and left ventricular diastolic dysfunction have prognostic significance as well. However, the relationship between diastolic dysfunction, arterial stiffness... 79 IgA nephropathy patients (aged 46 ± 11 years) and 50 controls were investigated. Tissue Doppler imaging was used to measure early (Ea) and late (Aa) diastolic velocities. Arterial stiffness was mea... We compared the IgAN patients to a similar cardiovascular risk group with a preserved eGFR. A strong correlation was found between Ea/Aa and SI (p < 0.001), also with PWVao (p < 0.001), just in IgAN, ... In chronic kidney disease, increased cardiac rigidity and vascular stiffness coexist with decreased renal function, which is directly connected to diastolic dysfunction and vascular stiffness. On the ...

Assessment of subclinical left ventricular systolic dysfunction in patients with asymptomatic severe aortic stenosis with preserved left ventricular systolic function by three-dimensional speckle tracking echocardiography.

Left ventricular dysfunction and remodeling can occur as a result of aortic valve stenosis (AS). Three-dimensional speckle tracking echocardiography (3D-STE) can detect early left ventricular myocardi... This study included 46 patients with asymptomatic severe AS but preserved LV systolic function (mean age 50.11 ± 12.66 years, LVEF 63.78 ± 3.95%, AS group) and 33 healthy subjects with no cardiovascul... The AS group had significantly thicker interventricular septum and posterior ventricular wall than the control group (1.49 ± .19 cm vs. .81 ± .09 cm, p < .001; 1.73 ± 1.71 cm vs. .81 ± .10 cm, p = .00... Our findings showed reductions in left ventricular global myocardial strains, particularly PSLS in patients suffering from asymptomatic severe AS in Bangladesh; this is consistent with other studies. ...

Left atrial strain parameters derived by echocardiography are impaired in patients with acute myocarditis and preserved systolic left ventricular function.

Data derived by cardiac magnetic resonance (CMR) feature tracking suggest that not only left ventricular but also left atrial function is impaired in patients with acute myocarditis. Therefore, we inv... 30 patients with acute myocarditis confirmed by CMR according to the Lake Louise criteria and 20 healthy controls were analyzed including global longitudinal strain (GLS) and left atrial (LA) strain p... In patients with acute myocarditis and preserved LVEF not only GLS but also LA reservoir function, LA conduit function and left atrial stiffness index as well as left atrial filling index were impaire...

The Use of Global Longitudinal Strain to Detect Subclinical Reduction in Left Ventricular Pump Function.

Left ventricular (LV) ejection fraction (LVEF) is not a sensitive marker of LV systolic function in a subset of patients with preserved EF. The relation between LV pump function and global longitudina... In total, 100 participants with LVEF of ≥50% were studied for demographic and echocardiographic data, including LVEF, stroke volume, SVI, COP, LV longitudinal strain assessments, apical 4-, 3-, and 2-... Reduced LV GLS was associated with lower SVI (35.6 ± 13.6 vs. 43.8 ± 12.7 mL/m 2 ; P = 0.01), lesser COP (5.4 ± 1.9 vs. 6.5 ± 2.1 l/min; P = 0.02), GLS had strong positive correlations with SVI ( r = ... Impaired LV strain is associated with lower LV pump function, presented as lower COP and lower SVI in patients with preserved EF even in the absence of clinical HF. It is of great importance to incorp...

Atrial paced rhythm and heart rate-dependent worsening of left atrial and ventricular function.

The response to the increase in heart rate (HR) could be characterized by failure in both left ventricular (LV) and left atrial (LA) functions. This study aimed to evaluate the relationship between th... In a group of patients with an implantable cardioverter defibrillator (ICD) or pacemaker, the atrial paced rhythm was progressively increased from 60 to 70, from 70 to 80, and from 80 to 90 beats per ... Of the 45 patients enrolled, a significant reduction in LAr was observed at higher HR. However, when the patients were dichotomized according to the HR-related response of LV-GLS, the worsening of LAr... In patients with atrial paced rhythm, the increase in HR could be associated with worsening of LA and LV functions, as assessed by two-dimensional speckle tracking analyses. These results offer new da...